Study finds CRISPR/Cas gene editing causes “chromatin fatigue” – another surprise mechanism by which it can produce unwanted ...

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

The fight for biodiversity is now a high-tech, high-finance arms race, and the Colossal Foundation is leading the charge.

Builders VC recently led a delegation of senior executives from four of its portfolio companies to Doha, engaging with Qatar ...

Biodegradable thermal packaging is revolutionizing the standards for transporting temperature-sensitive pharmaceuticals ...

An Iranian envoy to the UN office in Geneva called for the full, balanced, and non-discriminatory implementation of the ...

Xenotransplantation, involving organ transplants between species, offers a potential solution to the shortage of human donor organs. Advances in genetic ...

Scientists have produced the first genetically modified "decaf" coffee plant. The researchers managed to reduce the activity of key caffeine-making genes in the coffee species Coffea canephora. The ...

The advent of chimeric antigen receptor (CAR)-T cell therapy has marked the onset of a very promising option to treat solid tumors after its remarkable ...

From vaccines for elephants to cloning red wolves, The Colossal Foundation is advancing its conservation and de-extinction ...

The Colossal Foundation, the 501(c)(3) nonprofit arm of Colossal Biosciences, the world's first de-extinction company, today ...

Books hold a mirror to society, reflecting uncomfortable truths that some people would rather not see. Over the decades, ...